Enzo Biochem, Inc. (NYSE:ENZ) Declares $0.10 Dividend

Enzo Biochem, Inc. (NYSE:ENZ) announced a dividend on Tuesday, October 29th, NASDAQ reports. Investors of record on Friday, November 15th will be paid a dividend of 0.10 per share by the medical research company on Monday, December 2nd. The ex-dividend date is Friday, November 15th.

Enzo Biochem Stock Up 2.7 %

Enzo Biochem stock traded up $0.03 during mid-day trading on Wednesday, hitting $1.16. The company’s stock had a trading volume of 331,081 shares, compared to its average volume of 95,885. The firm’s 50 day moving average is $1.13 and its 200 day moving average is $1.11. Enzo Biochem has a 52-week low of $0.99 and a 52-week high of $1.50.

Wall Street Analyst Weigh In

Separately, StockNews.com initiated coverage on Enzo Biochem in a research note on Wednesday. They issued a “hold” rating for the company.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.